OncoResponse Alternatives & Competitors
12 companies similar to OncoResponse — Interrogating for Cures
Companies similar to OncoResponse
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...
Cambridge, United States
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
FogPharma
Until everything is druggable.
Cambridge, United States
Aulos Bioscience
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immune...
Larkspur, United States
Track all OncoResponse competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
Adagene
Redefining the design and discovery of therapeutic antibodies
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
Compugen
A clinical-stage cancer immunotherapy company and a pioneer in computational target discov...
Israel
Enara Bio
Advancing cancer immunotherapy by targeting the unconventional
Oxford, United Kingdom
Jounce Therapeutics, Inc.
Daring to create a world immune to cancer.
Cambridge, United States
Amphivena Therapeutics
Empowering Cancer Patients with Dual-Action Immuno-Oncology Biologics
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
About OncoResponse
OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer Center, which amplifies its capabilities in treating cancer. Utilizing a proprietary B-cell discovery platform, OncoRes...
Development of novel cancer immunotherapies, Discovery of human antibodies, Partnering with collaborators in immuno-oncology, Preclinical studies
Biopharmaceutical companies, Oncology researchers, Cancer patients, Clinical study collaborators
Immuno-oncology, Biotech, Cancer Immunotherapy, Antibody Platform, B-cell Discovery, Tumor Microenvironment, Monoclonal Antibodies, Immune Activation, TME Immunosuppression, Elite Cancer Responders, Novel Therapeutics, Myeloid Biology, Clinical Trials, Human Antibodies
B2B, B2D, Platform
Licensing, Performance Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches OncoResponse and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at OncoResponse on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
